Market Cap 35.89B
Revenue (ttm) 4.69B
Net Income (ttm) 1.02B
EPS (ttm) N/A
PE Ratio 27.00
Forward PE 25.84
Profit Margin 21.79%
Debt to Equity Ratio 0.12
Volume 206,144
Avg Vol 1,105,754
Day's Range N/A - N/A
Shares Out 146.63M
Stochastic %K 35%
Beta 0.78
Analysts Sell
Price Target $258.75

Latest News on RMD

Resmed Acquires VirtuOx

May 1, 2025, 9:00 AM EDT - 4 weeks ago

Resmed Acquires VirtuOx


ResMed: Cornering The Market In Sleep Solutions

Apr 24, 2025, 5:12 AM EDT - 5 weeks ago

ResMed: Cornering The Market In Sleep Solutions


ResMed Inc. (RMD) Q3 2025 Earnings Call Transcript

Apr 23, 2025, 7:16 PM EDT - 5 weeks ago

ResMed Inc. (RMD) Q3 2025 Earnings Call Transcript


Resmed Names Salli Schwartz as Chief Investor Relations Officer

Apr 21, 2025, 5:00 PM EDT - 6 weeks ago

Resmed Names Salli Schwartz as Chief Investor Relations Officer


Jan De Witte joins GHO Capital as Operating Partner

Feb 11, 2025, 4:30 AM EST - 4 months ago

Jan De Witte joins GHO Capital as Operating Partner

IART


Stock Of The Day: Trading The Range In ResMed

Feb 3, 2025, 12:59 PM EST - 4 months ago

Stock Of The Day: Trading The Range In ResMed


ResMed Inc. (RMD) Q2 2025 Earnings Call Transcript

Jan 30, 2025, 9:10 PM EST - 4 months ago

ResMed Inc. (RMD) Q2 2025 Earnings Call Transcript


ResMed CEO On Earnings, Sleep Apnea

Oct 29, 2024, 11:23 AM EDT - 7 months ago

ResMed CEO On Earnings, Sleep Apnea


ResMed Inc. (RMD) Q1 2025 Earnings Call Transcript

Oct 24, 2024, 11:14 PM EDT - 7 months ago

ResMed Inc. (RMD) Q1 2025 Earnings Call Transcript


My Top 15 High Growth Dividend Stocks For October 2024

Oct 3, 2024, 12:04 PM EDT - 8 months ago

My Top 15 High Growth Dividend Stocks For October 2024

ACN APH DPZ ELV GPN INTU MA


Why ResMed's Rally Is Just Getting Started

Sep 18, 2024, 11:30 AM EDT - 9 months ago

Why ResMed's Rally Is Just Getting Started